← Open Payments lookup

VIOLET DAKORA: Open Payments

NPI 1831557982 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,221 in 63 payments from 7 companies in 2025. Trend: 2023 $2,520 · 2024 $1,716 · 2025 $1,221

Food & beverage: $1,146Education: $76
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$326
Teva Pharmaceuticals USA, Inc.8$252
E.R. Squibb & Sons, L.L.C.12$197
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$124
Lundbeck LLC6$118
Janssen Pharmaceuticals, Inc5$109
Otsuka America Pharmaceutical, Inc.5$95

Products named: INGREZZA, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, UZEDY, AUSTEDO XR, SPRAVATO, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.